Abstract: BACKGROUND: the benefits of monitoring cerebral blood flow (CBF) in stroke patients are apparent. New techniques combining near infrared spectroscopy (NIRS) and indocyanine green (ICG) dye dilution to estimate cerebral hemodynamics are available. However, with transcutaneous NIRS and optodes applied over the skin, the signal is contaminated by extracerebral tissues. The objective is to develop a new brain tissue probe for combined monitoring of intracranial pressure (ICP), CBF and cerebral blood volume (CBV). METHODS: conventional intraparenchymal probes for ICP monitoring are supplied with optical fibers. The light is coupled into the brain tissue and collected after absorption and scattering with a light detector. Venous injections of 0.2 mg/kgbw ICG are performed. The mean transit time of ICG (mttICG), CBF and CBV are calculated. RESULTS: with a prototype of the probe in a first patient with subarachnoid hemorrhage 6 pairs of repetitive measurements were performed. Mean values were for mttICG 5.6 ± 0.2 s, CBF 22.3 ± 2.8 ml/100 g/min and CBV 2.1 ± 0.3 ml/100 g. CONCLUSIONS: NIR spectroscopy allows the synchronous determination of multiple parameters with one single device. By measurements in parallel with the NeMo Probe and NIRS optodes placed over the skin, new algorithms can be developed to subtract the extracerebral contamination from the NIRS signal.
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Summary:
Background: The benefits of monitoring cerebral blood flow (CBF) in stroke patients are apparent. New techniques combining near infrared spectroscopy (NIRS) and indocyanine green (ICG) dye dilution to estimate cerebral hemodynamics are available. However, with transcutaneous NIRS and optodes applied over the skin, the signal is contaminated by extracerebral tissues. The objective is to develop a new brain tissue probe for combined monitoring of intracranial pressure (ICP), CBF and cerebral blood volume (CBV). Results: With a prototype of the probe in a first patient with subarachnoid hemorrhage 6 pairs of repetitive measurements were performed. Mean values were for mttICG 5.6+0.2 sec, CBF 22.3+2.8 ml/100g/min and CBV 2.1+0.3 ml/100g.
Conclusions:
NIR spectroscopy allows the synchronous determination of multiple parameters with one single device. By measurements in parallel with the NeMo Probe and NIRS optodes placed over the skin, new algorithms can be developed to subtract the extracerebral contamination from the NIRS signal.
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Introduction:
The benefits of monitoring cerebral blood flow (CBF) in patients with subarachnoid hemorrhage, severe hemispheric stroke and head injury are apparent. Numerous techniques have been developed to estimate cerebral hemodynamics (1, 5, 10, 11, 14, 19) . However, each method has its own advantages and drawbacks. To date a suitable method for bedside CBF measurement, able to detect smaller areas of ischemia and easy to perform at the bedside is still lacking.
Optical methodologies may be the ideal instrument to monitor disease-related secondary brain injuries in instable patients in the environment of intensive care, emergency care and surgical units. New techniques combining near infrared spectroscopy (NIRS) and indocyanine green (ICG) dye dilution to estimate cerebral hemodynamics are available (3, 7, 8, 13, 15) .
However, transcutaneous NIRS with optodes applied over the skin is controversially discussed, because the NIRS signal is contaminated by extracerebral tissues (skin, skull, cerebrospinal fluid layer) (4, 6, 17) . To obtain measurement values directly from the brain tissue a conventional probe for intracranial pressure (ICP) monitoring can be supplied with optical fibers for NIRS. For patients with severe brain injuries and stroke, where ICP probes are installed anyway because of brain oedema and intracranial hypertension, a new combined NIRS ICP probe may offer enhanced modality without an additional surgical intervention.
The objective is to develop a new intraparenchymal probe for combined monitoring of ICP, brain temperature, CBF and cerebral blood volume (CBV) with NIRS and ICG dye dilution.
Methods:
The study was approved by the Ethics Committee of the University of Zurich. 
Discussion:
Originally, as scientific prototypes, the optical fibers for combined NIRS and ICP monitoring were first integrated into a conventional subdural probe for ICP-monitoring and tested in two patients (9) . Still, in clinical practice the use of ICP probes constructed as subdural types is not common yet, as intraparenchymal probes are preferred due to their higher measuring accuracy and their smaller diameter which makes their application less invasive (2, 16) . Therefore, the industrialized prototypes are now being produced as probes to be inserted directly into the brain tissue. The advantages of patches with NIRS optodes applied over the skin, is that they are strictly non-invasive. Several vascular territories, therefore, can be monitored over both hemispheres symmetrically. Furthermore, measurements with the NeMo Probe and optode patches over the skin in parallel, will allow for the development of algorithms to determine and subtract extracerebral contamination. In less severely ill patients, not requiring an ICP monitoring probe and in patients treated with full anticoagulation (e.g. during cardiopulmonary bypass surgery) the non invasive approach with optode patches attached over the skin and optimized algorithms may be the first choice.
In conclusion: The new combined NIRS ICP probe allows the determination of multiple parameters synchronously with one single device. By measurements in parallel with the NeMo Probe and NIRS optodes placed over the skin, new algorithms will be developed to determine the contribution from extracerebral tissues within the cumulative signal obtained by transcranial NIRS. The study was supported by NeMoDevices AG, Zuerich, Switzerland
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